- Home
- ONCO vs NXTS Comparison
ONCO vs NXTS Comparison
Compare ONCO & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.55
N/A
Current Price
$0.97
Company Overview
Basic Information| Metric | ONCO | NXTS |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 2.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ONCO | NXTS |
|---|---|---|
| Price | $0.55 | $0.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 539.0K | 34.3K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,524,116.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4217.31 | N/A |
| 52 Week Low | $0.05 | $0.86 |
| 52 Week High | $7.65 | $1.00 |
Technical Indicators
Market Signals| Indicator | ONCO | NXTS |
|---|---|---|
| Relative Strength Index (RSI) | 33.90 | 41.49 |
| Support Level | $0.07 | $0.86 |
| Resistance Level | $0.95 | N/A |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 19.66 | 33.36 |
Price Performance
Historical Comparison ONCO
NXTS
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.